About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:3800459
Allelic
Composition
Faslpr/Faslpr
Tg(CD2-Foxj1)#Stlp/0
Genetic
Background
MRL.Cg-Faslpr Tg(CD2-Foxj1)#Stlp
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Faslpr mutation (39 available); any Fas mutation (83 available)
Tg(CD2-Foxj1)#Stlp mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• inflammation observed is reduced compared to non-transgenic Faslpr mice
• reduced lymphadenopathy is observed compared to non-transgenic Faslpr mice
• diminished accumulation of CD3+ CD4- CD8- B220+ double negative T cells is observed in peripheral lymphoid organs
• peripheral CD4 counts are 8- to 10-fold reduced
• increased numbers of mature CD4+ thymocytes show defective migration in response to CCL19 in vitro, suggesting impaired ability to emigrate from the thymus
• reduced lymphadenopathy is observed compared to non-transgenic Faslpr mice
• double mutant mice display protection against murine lupus (reduced lymphadenopathy, autoantibody production and end-organ disease)
• anti-DNA autoantibodies are produced; however, these autoantibodies are not high affinity anti-dsDNA antibodies and likely only low affinity anti-ssDNA antibodies are present
• inflammation observed is reduced compared to non-transgenic Faslpr mice
• inflammation observed is reduced compared to non-transgenic Faslpr mice
• inflammation observed is reduced compared to non-transgenic Faslpr mice

hematopoietic system
• reduced lymphadenopathy is observed compared to non-transgenic Faslpr mice
• diminished accumulation of CD3+ CD4- CD8- B220+ double negative T cells is observed in peripheral lymphoid organs
• peripheral CD4 counts are 8- to 10-fold reduced
• increased numbers of mature CD4+ thymocytes show defective migration in response to CCL19 in vitro, suggesting impaired ability to emigrate from the thymus

renal/urinary system
• inflammation observed is reduced compared to non-transgenic Faslpr mice

endocrine/exocrine glands
• inflammation observed is reduced compared to non-transgenic Faslpr mice

digestive/alimentary system
• inflammation observed is reduced compared to non-transgenic Faslpr mice

liver/biliary system
• inflammation observed is reduced compared to non-transgenic Faslpr mice

respiratory system
• inflammation observed is reduced compared to non-transgenic Faslpr mice

growth/size/body
• reduced lymphadenopathy is observed compared to non-transgenic Faslpr mice


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
01/28/2026
MGI 6.24
The Jackson Laboratory